Skip to main content
SpringerLink
Log in

Pharmacologic treatment of attention-deficit hyperactivity disorder

  • Symposium on Developmental and Behavioral Disorders-II
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Attention-deficit hyperactivity disorder (ADHD) is highly prevalent in children and adolescents. Highly effective pharmacological treatments are available that allow the child and the adolescent to function at his/her full potential. Various preparations of methylphenidate and amphetamines have been used for a long time in the treatment of ADHD. This article reviews these and some of the newer drugs used in the treatment of ADHD, including atomoxetine and bupropion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greydanus DE, Sloane MA, Rappley MD. Psychopharmacology of ADHD in adolescents.Adolesc Med 2002; 13: 599–624.

    PubMed  Google Scholar 

  2. Greydanus DE, Pratt HD, Sloane MAet al. Attention-deficit/ hyperactivity disorder in Children and adolescents: Interventions for a complex costly clinical conundrum.Pediatr Clin North Am 2003; 50: 1049–1092.

    Article  PubMed  Google Scholar 

  3. Greydanus DE. Psychopharmacology of ADHD in adolescents: Quo vadis?Psychiatr Times 2003; 20: 5–9.

    Google Scholar 

  4. National Institute of Mental Health (NIMH).Attention Deficit Hyperactivity Disorder. NIMH, NIH Publication No. 01-4589, 2001. Available at: http://www.nimh.nih.gov/publicat/ helpchild.cfm.

  5. National Institute of Mental Health.NIMH Research on Treatment for Attention Deficit Hyperactivity Disorder (ADHD): The Multimodal Treatment Study—Questions and Answers. Washington, DC: NIMH, 2000. Available at:http://www.nimh.nih.gov/events/mtaqa.cfm

    Google Scholar 

  6. National Institute of Health (NIH).Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. NIH Consensus Statement Online 1998: Nov 16–18; [cited year, month, day]; 16(2): 1–37.

    Google Scholar 

  7. Pratt HD. Neurodevelopmental Issues in the assessment and treatment of deficits in attention, cognition, and learning during adolescence.Adolesc Med 2002; 13(3): 579–598.

    PubMed  Google Scholar 

  8. Reiff MI, Stein MT. ADHD evaluation and diagnosis: A practical approach to office practice.Pediatr Clin North Am 2003; 50: 1019–1048.

    Article  PubMed  Google Scholar 

  9. Staufer WB, Greydanus DE. Attention-devicit/hyperactivity disorder psychopharmacology for college students.Pediatr Clin North Am 2005; 52: 71–84.

    Article  PubMed  Google Scholar 

  10. Wolraich ML, Wibbelsman CJ, Brown TE. ADHD: A review.Pediatrics 2005; 115: 749–757.

    Article  Google Scholar 

  11. The International Classification of Diseases, 10th ed. (ICD-10), WHO, 1993.

  12. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Text Revision. Washington, DC: Author, 2000; 85–93.

    Google Scholar 

  13. Wolraich ML, Felice ME.The Classification of Child and Adolescent Mental Diagnoses in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC): Child and Adolescent Version. Elk Grove Village, IL; American Academy of Pediatrics, 1986, 93–110.

    Google Scholar 

  14. Barkley RA. Attention-deficit/hyperactivity disorder. Sci Am 1998; 66–71.

  15. Barkley RA, ed.Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis, 2d edn. New York; Guilford Press, 1998.

    Google Scholar 

  16. Stein MT. ADHD: The diagnostic process from different perspectives.Dev Behav Pediatr 2004; 25: 53–57.

    Article  Google Scholar 

  17. Cunningham CF. A large-group, community-based, family systems approach to parent training. In: Barkley RA, ed.Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis, 2d ed. New York: Guilford Press, 1998.

    Google Scholar 

  18. Swanson JM and MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in effectiveness and growth after the end of treatment.Pediatrics 2004; 113: 762–769.

    Article  Google Scholar 

  19. Whalen CK, Henker B. Therapies for hyperactive children: Comparisons, combinations, and compromises.J Consult Clin Psychol 1991; 59(1): 126–137.

    Article  PubMed  CAS  Google Scholar 

  20. Bradley C. The behavior of children receiving benzedrine.Am J Psychiatry 1937; 94: 577–585.

    Google Scholar 

  21. Clarke SD. ADHD in adolescence.J Adolesc Health 2000; 127: 77–78.

    Article  Google Scholar 

  22. Pliszka SR, Greenhill LL, Crismon MLet al. The Texas children’s medication algorithm project: report of the texas consensus conference panel on medication treatment of childhood, attention-deficit/hyperactivity disorder. Part I.J Am Acad Child Adolesc Psychiatry 2001; 39: 908–919.

    Article  Google Scholar 

  23. Rappley MD. ADHD.N Engl J Med 2005; 352: 123–125.

    Article  Google Scholar 

  24. Schubiner H, Robin AL, Young J. Attention-deficit/ hyperactivity disorder in adolescent males.Adolesc Med 2003; 14: 663–676.

    PubMed  Google Scholar 

  25. Wender EH. Managing stimulant medication for attention-deficit/hyperactivity disorder: An update.Pediatr Rev 2002; 23: 234–236.

    Article  PubMed  Google Scholar 

  26. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CKet al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers.J Dev Behav Pediatr 2001; 22: 60–73.

    PubMed  CAS  Google Scholar 

  27. Solanto MV, Arnsten AFT, Castellanos FX. The neuroscience of stimulant drug action in ADHD. In Solanto MV, Arnsten AFT, Castellanos FX, eds.Stimulant Drugs and ADHD. London; Oxford University Press, 2001; 355–379.

    Google Scholar 

  28. Varley C: Sudden death of a child treated with imipramine.J Child Adolesc Psychopharmacol 2000; 10: 321–325.

    Article  PubMed  CAS  Google Scholar 

  29. Varley CK. Sudden death related to selected tricyclic antidepressants in children: Epidemiology, mechanisms and clinical implications.Paediatr Drugs 2001; 3: 613–627.

    Article  PubMed  CAS  Google Scholar 

  30. Atomoxerine: Strattera revisited.Med Lett 2004; 46 : 65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatrics and Human Development, Michigan State University, Kalamazoo Center for Medical Studies Kalamazoo, Michigan, USA

    Donald E. Greydanus

Authors
  1. Donald E. Greydanus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald E. Greydanus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greydanus, D.E. Pharmacologic treatment of attention-deficit hyperactivity disorder. Indian J Pediatr 72, 953–960 (2005). https://doi.org/10.1007/BF02731672

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02731672

Key words

Search

Navigation